Wenbo Chen, PhD

Quantatitive Pharmacology and Pharmacometrics
Merck & Co., Inc.

Poster(s):

• (S-033) The Dose and Dosing Schedule Selection for an Investigational Immuno-Oncology Drug Based on a Pharmacokinetics and Pharmacodynamic Model of Tolerance
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT